Skip to main content
Caplight Logo









Nodcure Inc.

Nodcure Inc.

Private
GwangjuHealthcare & Life Scienceshttps://nodcure.com/

Last Round

Grant

Sep 1, 2026

Total Funding Raised

$2.16M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nodcure Inc. is a biotechnology company that develops microbiome-based therapeutic drugs and functional materials for infectious, immune, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware + Subscription

AI Layer

Non-AI

Keywords

microbiome therapeuticsdrug discoveryhistopathology testingfunctional health productsprobioticsgut healthbiotech R&Ddietary supplementstechnology transferpreclinical studiespet nutritionbio-pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nodcure Inc. Comparables

Compare Nodcure Inc. with similar companies based on industry and business-model similarity.

Nodcure Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoBiome Inc.
86%
AtoGen Co., Ltd.
83%
Enterobiome Inc.
83%

Nodcure Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2026
Series ADec 14, 2025
VC RoundJan 16, 2024
GrantOct 11, 2023
SeedMay 31, 2023

Nodcure Inc. Investors

Notable investors and investment history

Nodcure Inc. investors
InvestorRounds
KOTECSeed
Korea Science & Technology HoldingsGrant, Seed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Secured $220K in grant funding.

  • Dec 14, 2025

    Completed a Series A funding round.

Nodcure Inc. Filings

Explore SEC and related filing metadata, where available.

Nodcure Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nodcure Inc.'s valuation, stock price, and market status.

Is Nodcure Inc. a public or private company?

Nodcure Inc. is a private company.

What is the current stock price of Nodcure Inc.?

Nodcure Inc. is a private company with no public stock price. Caplight tracks Nodcure Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Nodcure Inc. worth (valuation)?

Valuation information for Nodcure Inc. is not publicly available.

Can I buy Nodcure Inc. stock?

Nodcure Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nodcure Inc.'s last funding round?

Nodcure Inc.'s most recent funding round was Grant on September 1, 2026.

Who are the main investors in Nodcure Inc.?

Key investors in Nodcure Inc. include KOTEC, Korea Science & Technology Holdings, Government of South Korea.

Will Nodcure Inc. IPO soon?

No public IPO plans have been announced for Nodcure Inc..

How can I track Nodcure Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nodcure Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGwangju
Year Founded2021
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?